Hemodynamic Monitoring in the Diagnosis and Management of Heart Failure, An Issue of Heart Failure Clinics, 1st Edition
Authors :
William T. Abraham & Ragavendra R. Baliga
Heart failure incidence increases with age and because the oldest segment of the population in Western countries is the fastest growing, the prevalence of heart failure is expected to increase. Understanding the signs and symptoms of heart failure is ...view more
Heart failure incidence increases with age and because the oldest segment of the population in Western countries is the fastest growing, the prevalence of heart failure is expected to increase. Understanding the signs and symptoms of heart failure is therefore of increasing necessity for physicians. Hemodynamic monitoring provides data on blood flow and pressure to assist physicians in determining the status of the patient's heart and in managing heart failure. This issue provides a detailed picture of the various options for assessing hemodynamics, including clinical assessment, echocardiography, transthoracic impedance cardiography, pulmonary artery catheters, B-type natriuretic peptide levels, and implantable devices.
Heart failure incidence increases with age and because the oldest segment of the population in Western countries is the fastest growing, the prevalence of heart failure is expected to increase. Understanding the signs and symptoms of heart failure is therefore of increasing necessity for physicians. Hemodynamic monitoring provides data on blood flow and pressure to assist physicians in determining the status of the patient's heart and in managing heart failure. This issue provides a detailed picture of the various options for assessing hemodynamics, including clinical assessment, echocardiography, transthoracic impedance cardiography, pulmonary artery catheters, B-type natriuretic peptide levels, and implantable devices.
Author Information
By William T. Abraham, MD, FACP, FACC, FAHA and Ragavendra R. Baliga, MD, MBA, FACP, FRCP, FACC, Inaugural Director, Cardio-Oncology Center of Excellence Professor of Internal Medicine The Ohio State University Wexner Medical Center
https://www.us.elsevierhealth.com/hemodynamic-monitoring-in-the-diagnosis-and-management-of-heart-failure-an-issue-of-heart-failure-clinics-9781437704853.html5950Hemodynamic Monitoring in the Diagnosis and Management of Heart Failure, An Issue of Heart Failure Clinicshttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9781437704853.jpg69.2998.99USDInStock/Medicine/Cardiology/Clinics/Clinics464388725525504113841826925145120Heart failure incidence increases with age and because the oldest segment of the population in Western countries is the fastest growing, the prevalence of heart failure is expected to increase. Understanding the signs and symptoms of heart failure is therefore of increasing necessity for physicians. Hemodynamic monitoring provides data on blood flow and pressure to assist physicians in determining the status of the patient's heart and in managing heart failure. This issue provides a detailed picture of the various options for assessing hemodynamics, including clinical assessment, echocardiography, transthoracic impedance cardiography, pulmonary artery catheters, B-type natriuretic peptide levels, and implantable devices. Heart failure incidence increases with age and because the oldest segment of the population in Western countries is the fastest growing, the prevalence of heart failure is expected to increase. Understanding the signs and symptoms of heart failure is therefore of increasing necessity for physicians. Hemodynamic monitoring provides data on blood flow and pressure to assist physicians in determining the status of the patient's heart and in managing heart failure. This issue provides a detailed picture of the various options for assessing hemodynamics, including clinical assessment, echocardiography, transthoracic impedance cardiography, pulmonary artery catheters, B-type natriuretic peptide levels, and implantable devices.00add-to-cart97814377048532011 and earlierProfessionalBy William T. Abraham, MD, FACP, FACC, FAHA and Ragavendra R. Baliga, MD, MBA, FACP, FRCP, FACC20091Book178w x 254h (7.00" x 10.00")Saunders240Mar 22, 2009IN STOCK - This may take up to 5 business days to shipBy <STRONG>William T. Abraham</STRONG>, MD, FACP, FACC, FAHA and <STRONG>Ragavendra R. Baliga</STRONG>, MD, MBA, FACP, FRCP, FACC, Inaugural Director, Cardio-Oncology Center of Excellence Professor of Internal Medicine The Ohio State University Wexner Medical CenterClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
